CTSNet Podcasts

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Dr. John Forrest, a cardiologist and Director of both Interventional Cardiology and the Structural Heart Disease Program at Yale Medicine, New Haven, CT, USA, about a paper he authored titled “Six-Year Outcomes After Transcatheter vs Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis,” published by the Journal of the American College of Cardiology.

Chapters

00:00 Intro 

02:38 TAVR vs SAVR Context 

03:54 CDC WONDER Data, TAVR SAVR 

05:37 JANS 1, TAVR vs SAVR 5-Year Outcomes 

07:31 JANS 2, Temporary MCS Devices Landscape 

09:17 JANS 3, Pulm Resection Post-CABG 

10:23 JANS 4, PRE-HIIT Randomized Trial 

12:36 Career Center 

13:10 Video 1, Redo MVR After VIV TAVR 

15:37 Video 2, Repair After Acute Intramural Hematoma 

18:01 Video 3, Acute Severe MR Repair 

19:36 Dr. Forrest, 6-Year TAVR vs SAVR 

44:49 Upcoming Events 

45:33 The Lifeline Podcast 

They explored other randomized trials involving high-risk and intermediate-risk patients with aortic stenosis and examined the specific goals of this low-risk trial. The discussion then delved into the trial’s results, highlighting that there was no significant difference in the composite endpoint of all-cause mortality or disabling stroke. However, a noteworthy finding was that the transcatheter aortic valve replacement (TAVR) arm experienced a higher reintervention rate compared to surgery, primarily due to an increased incidence of aortic regurgitation. They also addressed factors such as valve dilation, stents, and various reasons for surgical valve failure. Additionally, they examined the similarities between this trial and other partner trials and the future for low-risk patients with aortic stenosis.  

Joel also highlights recent JANS articles on the updated five-year outcomes of transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low- to intermediate-surgical risk, a United States nationwide analysis on the changing landscape of temporary mechanical circulatory support devices in the new heart allocation system, pulmonary resection post-coronary artery bypass grafting, and a randomized controlled trial on the preoperative exercise to improve fitness in patients undergoing complex surgery for cancer of the lung or esophagus (PRE-HIIT). 

In addition, Joel explores redo mitral valve replacement after previous valve-in-valve mitral TAVR, aortic repair after acute intramural hematoma, and repair of acute severe mitral regurgitation due to iatrogenic papillary muscle rupture. Before closing, Joel highlights upcoming events in CT surgery.   

JANS Items Mentioned 

1.) Updated 5-Year Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low- to Intermediate-Surgical Risk 

2.) The Changing Landscape of Temporary Mechanical Circulatory Support Devices in the New Heart Allocation System—A United States Nationwide Analysis 

3.) Pulmonary Resection Post-Coronary Artery Bypass Grafting: Feasible, but Right-Sided Procedures Demand Caution 

4.) Preoperative Exercise to Improve Fitness in Patients Undergoing Complex Surgery for Cancer of the Lung or Esophagus (PRE-HIIT): A Randomized Controlled Trial 

CTSNet Content Mentioned 

1.) Redo Mitral Valve Replacement After Previous Valve-in-Valve Mitral TAVR 

2.) Aortic Repair After Acute Intramural Hematoma  

3.) Repair of Acute Severe Mitral Regurgitation Due to Iatrogenic Papillary Muscle Rupture 

Other Items Mentioned 

1.) Six-Year Outcomes After Transcatheter vs Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis 

2.) The Lifeline: End-Tidal Carbon Dioxide Monitoring in Cardiac Surgical Emergencies 

3.) Instructional Video Competition    

4.) Career Center  

5.) CTSNet Events Calendar 

Disclaimer

The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Drs. Mateo Marin-Cuartas, CTSNet JANS Editor and cardiac surgeon at the University Department of Cardiac Surgery at Leipzig Heart Centre University Hospital in Leipzig, SN, Germany; and Samuel Heuts, a cardiothoracic surgeon in the Department of Cardiothoracic Surgery at Maastricht University Medical Center in Maastricht, LI, about a paper they authored titled “Updated 5-Year Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low- to Intermediate-Surgical Risk,” published in Heart, a journal produced by the British Medical Journal.

Chapters

00:00 Intro
01:51 JANS 1, 6-Year Outcomes TAVR vs SAVR
06:45 JANS 2, Evolut THV Postdilation
09:22 Video 2, TAVI in SAVR Explantation
11:10 JANS 3, High Risk Increasing Adoption of DCD
13:17 JANS 4, Lobar Quantitation for Assessment
15:16 Video 1, Narayana Robotic AVR
17:23 Video 3, Extended Resections Podcast
18:30 Dr. Marin-Cuartas & Heuts, TAVR vs SAVR
36:42 Upcoming Events
37:32 Instructional Video Competition
38:55 Career Center

They discussed the motivations behind the creation of this paper and provided insights into its Bayesian hierarchical design. Key findings included the five-year all-cause mortality rates and the risk of stroke associated with the procedures. They also referenced other studies with similar findings, such as a recently published paper from the Journal of the American College of Cardiology on the “Six-Year Outcomes After Transcatheter vs Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis.” Finally, they explored the future of transcatheter aortic valve implantation and surgical aortic valve replacement.  

Joel also highlights recent JANS articles on the six-year outcomes after transcatheter vs surgical aortic valve replacement in low-risk patients with aortic stenosis, postdilation of Evolut transcatheter heart valves, insights into current practices in the United States regarding increasing adoption of donation after circulatory death in high-risk heart transplant recipients, and the value of V/Q SPECT/CT lobar quantitation for pre-treatment assessment of lung malignancy. 

In addition, Joel explores robotic-assisted aortic valve replacement, TAVI in SAVR explantation, and an episode of The Atrium podcast featuring host Dr. Alice Copperwheat speaking with Dr. Maninder Kalkat about extended resections. Before closing, Joel highlights upcoming events in CT surgery.   

JANS Items Mentioned 

1.) Six-Year Outcomes After Transcatheter vs Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis 

2.) Postdilation of Evolut Transcatheter Heart Valves: Insights From Bench Testing 

3.) Increasing Adoption of Donation After Circulatory Death in High Risk Heart Transplant Recipients: Insights Into Current Practices in the United States 

4.) The Value of V/Q SPECT/CT Lobar Quantitation for Pre-Treatment Assessment of Lung Malignancy 

CTSNet Content Mentioned 

1.) Robotic-Assisted Aortic Valve Replacement  

2.) TAVI in SAVR Explantation: A Two-Step Technique for Successful Removal  

3.) The Atrium: Extended Resections  

Other Items Mentioned 

1.) Updated 5-Year Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low- to Intermediate-Surgical Risk 

2.) The Lifeline 

3.) Instructional Video Competition    

4.) Career Center  

5.) CTSNet Events Calendar 

Disclaimer

The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

In this first edition of the new CTSNet podcast, The Lifeline, host and nurse educator Jill Ley, Clinical Professor at the University of California San Francisco School of Nursing, Founder of the Essentials of Cardiac Surgical Resuscitation, and former Cardiac Surgery Clinical Nurse Specialist at California Pacific Medical Center in San Francisco, CA, USA, speaks with expert guest Barbara McLean, a Critical Care Clinical Nurse Specialist at Grady Memorial Hospital in Atlanta, GA, USA. They discuss end-tidal carbon dioxide (EtCO2) monitoring in cardiac surgical emergencies. 

Chapters

00:00 Intro

01:30 End-Tidal CO2 Monitoring Overview

09:16 Case 1

13:52 Case 2

19:57 Outlier Cases

21:01 Global Application

Mclean began by providing an overview of EtCO2, including bedside interpretation, values for rapid non-invasive cardiopulmonary evaluation during acute decompensation, critical values that warrant intervention, and how to differentiate ventilation and perfusion abnormalities, metabolic acidosis, hypoventilation, hyperventilation, and arterial CO2. They then discuss various case studies outlining postoperative outcomes and the symptoms patients were experiencing emphasizing this important monitoring modality to aid in accurate and timely clinical assessment during complex emergencies. 

Every month, The Lifeline features intensive care specialists sharing their expert insights into the rapid and effective management of critically ill cardiac surgical patients. Don’t miss next month’s episode! 

Disclaimer

The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Dr. Niv Ad, Editor-in-Chief of the journal Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery and professor of surgery at Johns Hopkins University School of Medicine in Baltimore, Maryland, USA, about the journal.

Chapters

00:00 Intro

02:04 JANS 1, Adverse Effects Statin Therapy

06:21 JANS 2, Mortality & Reintervention, Robotic MR

09:15 JANS 3, Balloon vs Self Expanding Transcath Valves

11:41 JANS 4, Transcath Aortic Valve in MV Replacement

13:54 Career Center

14:33 Video 1, Endo Cone Repair w Ebstein Anomaly

16:26 Video 2, Retrograde Cardioplegia Cath Placement

17:19 Video 3, Standardized Strategy, Rheumatic MV Disease

20:31 Dr. Ad, Innovations Journal

31:05 Upcoming Events

31:38 New Podcast, The Lifeline

32:15 Closing

They discussed the main topics and procedures covered by Innovations, highlighting its double-blind peer-review process and the special feature section. Additionally, they provided tips for those interested in submitting to the journal.  

Joel also highlights recent JANS articles on a meta-analysis of double-blind randomized controlled trials for the assessment of adverse effects attributed to statin therapy in product labels, mortality and reintervention after robotic mitral repair in the United States, the three-year results of the LYTEN trial on balloon- vs self-expanding transcatheter valves for failed small surgical aortic, and the first-in-human study on transcatheter aortic valve-in-mechanical valve replacement. 

In addition, Joel explores an endoscopic cone repair in an adult patient with Ebstein anomaly, an alternative cannulation site for the placement of a retrograde cardioplegia catheter, and a standardized surgical management strategy for rheumatic mitral valve disease. Before closing, Joel highlights upcoming events in CT surgery.   

JANS Items Mentioned 

1.) Assessment of Adverse Effects Attributed to Statin Therapy in Product Labels: A Meta-Analysis of Double-Blind Randomised Controlled Trials 

2.) Mortality and Reintervention After Robotic Mitral Repair in the United States 

3.) Balloon- Versus Self-Expanding Transcatheter Valves for Failed Small Surgical Aortic Bioprostheses: 3-Year Results of the LYTEN Trial 

4.) Transcatheter Aortic Valve-in-Mechanical Valve Replacement: A First-in-Human Study  

CTSNet Content Mentioned 

1.) Endoscopic Cone Repair in an Adult Patient With Ebstein Anomaly  

2.) Placement of a Retrograde Cardioplegia Catheter: An Alternative Cannulation Site 

3.) Standardized Surgical Management Strategy for Rheumatic Mitral Valve Disease 

Other Items Mentioned 

1.) Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery 

2.) The Lifeline 

3.) Career Center  

4.) CTSNet Events Calendar 

Disclaimer

The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

In this episode of The Atrium, host Dr. Alice Copperwheat speaks with Dr. Maninder Kalkat, a consultant cardiothoracic surgeon in the Regional Department of Thoracic Surgery at University Hospital Birmingham, about extended resections.  

Chapters

00:00 Intro 

01:07 Inspiration & Areas of Interest 

03:23 Definition & Classification 

09:28 History 

10:16 Preop Considerations 

19:07 Operating Team Plan 

22:23 Fitness for Surgery 

23:55 Airway Resections 

31:33 Chest Wall Resections 

36:17 Reconstructive Material 

38:43 Vascular Resections 

43:53 Postoperative Care 

47:59 Future of Extended Resections 

50:15 Summary 

50:48 Surgery Training Tips

They provided an overview of extended resections, including the definition, indications, and examples, as well as the history of extended resections. They also discussed preoperative considerations and examined airway resections, detailing what it is, indications, and the technical principles of the operation. Additionally, they explored chest wall resections, including the definition, indications, and technical principles. Drs. Copperwheat and Kalkat also examined vascular resections, highlighting what they are, indications, and the technical aspects involved. They also reviewed postoperative considerations, complications, and outcomes. Finally, they shared training tips, future directions, and key principles in extended resections.  

The Atrium is a monthly podcast presenting clinical and career-focused topics for residents and early career professionals across all cardiothoracic surgery subspecialties. Keep an eye out for next month’s episode.  

Disclaimer

The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.